Zobrazeno 1 - 10
of 111
pro vyhledávání: '"D.G. Pectasides"'
Autor:
F-I.D. Dimitrakopoulos, A. Goussia, G.A. Koliou, K. Dadouli, A. Batistatou, H.P. Kourea, M. Bobos, P. Arapantoni-Dadioti, O. Tzaida, T. Koletsa, S. Chrisafi, M. Sotiropoulou, A. Papoudou-Bai, I. Nicolaou, A. Charchanti, D.G. Pectasides, A. Koutras, F. Zagouri, H. Gogas, G. Fountzilas
Publikováno v:
ESMO Open. 8:101302
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c9d43b157bdcae785a9c2a13d8c4da7
https://doi.org/10.1016/j.esmoop.2023.101302
https://doi.org/10.1016/j.esmoop.2023.101302
Autor:
A. Psyrri, Alexandra Papoudou-Bai, D.G. Pectasides, Helen Gogas, Georgios Pentheroudakis, Sofia Chrisafi, I. Nicolaou, Maria Sotiropoulou, Gerassimos Aravantinos, C Petraki, C. Christodoulou, Flora Zagouri, Angelos Koutras, Anna Batistatou, G-A Koliou, Triantafyllia Koletsa, G. Fountzilas, Helen P. Kourea, Mattheos Bobos, Petroula Arapantoni-Dadioti, Vasiliki Kotoula, Ioannis Efstratiou, A. Visvikis
Publikováno v:
Cancer Research. 79:P4-08
Background - aim: Information on the prognostic role of cytotoxic CD8+ T cells in the era of modern adjuvant CT is limited. The primary objective of the present report is to assess the prognostic impact of CD8+ cells in patients with intermediate or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e260508660d55a779cbfad892f6d158
https://doi.org/10.1158/1538-7445.sabcs18-p4-08-13
https://doi.org/10.1158/1538-7445.sabcs18-p4-08-13
Autor:
G. Fountzilas, Angelos Koutras, E. Razis, Konstantine T. Kalogeras, Epaminontas Samantas, Dimitris Bafaloukos, T Economopoulos, Kyriaki Papadopoulou, Vasiliki Kotoula, G-A Koliou, D.G. Pectasides, Athanasios Kotsakis, Panagiota Economopoulou, Georgios Pentheroudakis, Pavlos Papakostas, C. Christodoulou
Publikováno v:
Cancer Research. 79:P2-08
Background-aim: SRC, CDKN1B and JAK2 play a crucial role in the coordination and facilitation of cell-signaling pathways controlling a wide range of cellular functions. In the present study, we investigated the prognostic significance and clinical ut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bb8aa2ae52a6ae4809811a3290eae25
https://doi.org/10.1158/1538-7445.sabcs18-p2-08-20
https://doi.org/10.1158/1538-7445.sabcs18-p2-08-20
Autor:
N. Spathas, A. Goussia, G.A. Koliou, H. Gogas, F. Zagouri, M. Bobos, D.G. Pectasides, E. Galani, A. Koutras, G. Zarkavelis, E. Saloustros, D. Bafaloukos, C. Karanikiotis, G. Aravantinos, A. Psyrri, E. Razis, A. Koumarianou, E. Res, H. Linardou, G. Fountzilas
Publikováno v:
Annals of Oncology. 33:S136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e622b46e0cddf21040de8872a355df70
https://doi.org/10.1016/j.annonc.2022.03.042
https://doi.org/10.1016/j.annonc.2022.03.042
Autor:
Helen Gogas, Elke Veltrup, Charisios Karanikiotis, K. Manousou, Georgios Lazaridis, M-A Dimopoulos, Angelos Koutras, Marinos L. Tsiatas, D.G. Pectasides, Georgios Pentheroudakis, Konstantine T. Kalogeras, Epaminontas Samantas, Dimitris Bafaloukos, Flora Zagouri, P. Kosmidis, Ralph M. Wirtz, G. Fountzilas, Pavlos Papakostas, C. Christodoulou, C Petraki
Publikováno v:
Cancer Research. 78:P1-07
Background: Tumor-infiltrating lymphocytes (TILs) have been shown to be of prognostic value in several cancer types. In early breast cancer, TILs have a prognostic utility, as well, especially in HER2-positive and triple-negative breast cancer (TNBC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::049fa1d01419d4c0ea45fcf0c34d4609
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-03
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-03
Autor:
Vasiliki Kotoula, Dimitris Bafaloukos, Kyriaki Papadopoulou, Pavlos Papakostas, Kalliopi Petraki, C. Christodoulou, Anna Batistatou, Georgios Pentheroudakis, Eleftheria Tsolaki, Mattheos Bobos, D.G. Pectasides, Sofia Chrisafi, George Kouvatseas, E. Razis, S. Pervana, Angelos Koutras, A. Psyrri, Konstantine T. Kalogeras, G-A Koliou, G. Fountzilas, Haralabos P. Kalofonos
Publikováno v:
Cancer Research. 78:P1-07
Background-aim: Metastatic breast cancer (MBC) is an incurable disease. Trastuzumab, a recombinant humanized monoclonal antibody, was found to significantly prolongsurvival of patients with metastatic HER2 over-expressing and/or amplified breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::203e352a3392378a97585c064b26f841
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-24
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-24
Autor:
Georgios Rigakos, Achilleas Achilleos, Maria Theochari, C. Papadimitriou, Gerassimos Aravantinos, Georgios Oikonomopoulos, Philippos C. Patsalis, Adamantia Nikolaidi, Pavlos Papakostas, Anna Koumarianou, Christos Dervenis, P. Kosmidis, Georgios Zarkavelis, Elena Fountzilas, A. Psyrri, Athina Christopoulou, Alexia Eliades, Konstantinos Ferentinos, Georgia-Angeliki Koliou, D.G. Pectasides, G. Fountzilas, Joseph Sgouros
Publikováno v:
Annals of Oncology. 31:S217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3f66c066a2a14faf65196073e63d310
https://doi.org/10.1016/j.annonc.2020.04.017
https://doi.org/10.1016/j.annonc.2020.04.017
Autor:
Alexios Papanikolaou, Georgia-Angeliki Koliou, Eleni Vrettou, Gerassimos Aravantinos, G. Fountzilas, D.G. Pectasides, Dimitrios Haidopoulos, Elena Fountzilas, A. Papoudou-Bai, Georgios Oikonomopoulos, A. Charchanti, Roubini Zakopoulou, Christos Poulios, Flora Zagouri, K. Chatzopoulos, P. Foukas, Anna Goussia, Vasiliki Kotoula, A. Visvikis, Georgios Pentheroudakis
Publikováno v:
Annals of Oncology. 30:v416
Background The characterization of the adaptive immune landscape in epithelial ovarian cancer (EOC) is of paramount importance for the stratification of patients (pts) for therapeutic interventions, especially in the context of immunotherapy. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e52422ad26e660b9abd0b4b8fa55d27
https://doi.org/10.1093/annonc/mdz250.027
https://doi.org/10.1093/annonc/mdz250.027
Autor:
Helen Gogas, Gerassimos Aravantinos, A. Psyrri, Helena Linardou, Georgios Pentheroudakis, Pavlos Papakostas, C. Christodoulou, E. Razis, Elena Fountzilas, P. Kosmidis, A. Christopoulou, Epaminontas Samantas, Anna Koumarianou, D.G. Pectasides, G. Fountzilas, Angelos Koutras, Georgia-Angeliki Koliou, Dimitris Bafaloukos, Charisios Karanikiotis, Flora Zagouri
Publikováno v:
Annals of Oncology. 30:v66
Background The principles of dose-dense (dd) and sequential (s) chemotherapy (CT) were introduced in the adjuvant setting by HeCOG in 1997. We aimed to explore the long-term clinical benefit and safety of treatment of adjuvant dds-CT in patients (pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb07e996c644d07ed92204ef74b8834d
https://doi.org/10.1093/annonc/mdz240.021
https://doi.org/10.1093/annonc/mdz240.021
Autor:
George Dimitriadis, E. Maratou, Giannis Mountzios, Amanda Psyrri, D.G. Pectasides, Panagiota Economopoulou, Stavroula Giannouli, Nikolaos K. Kentepozidis, Helen Gogas, Ioannis Kotsantis
Publikováno v:
Annals of Oncology. 30:ii10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::362e70f7cc245330924c65345ba560fd
https://doi.org/10.1093/annonc/mdz073.009
https://doi.org/10.1093/annonc/mdz073.009